GRAZAX®: a sublingual immunotherapy vaccine for Hay fever treatment: from concept to commercialization

• Κύριοι συγγραφείς: Domingo Barber (Συγγραφέας), Pilar Rico (Συγγραφέας), Carlos Blanco (Συγγραφέας), Montserrat Fernandez-Rivas (Συγγραφέας), Maria Dolores Ibañez (Συγγραφέας), Maria M. Escribese (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Taylor & Francis Group, 2019-12-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Allergen immunotherapy has been used for more than 100 y, but only recently underlying immunological mechanisms have started to be understood. New Allergy vaccines are now considered to be full pharmaceutical products, that should comply with general as well as specific pharmaceutical legal framewor...